Latanoprost NDC 25021-001

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-001-02	25021000102	1 BOTTLE in 1 CARTON (25021-001-02) / 2.5 mL in 1 BOTTLEMarketed from Jul 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Latanoprost
Generic name (nonproprietary): latanoprost
Active ingredients: Latanoprost — 50 ug/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218257
Marketing start: Jul 15, 2025
Listing expires: Dec 31, 2026
Identifiers: Product ID 25021-001_8ce78c02-d0b0-4629-b51d-0c674c6e2e43SPL ID 8ce78c02-d0b0-4629-b51d-0c674c6e2e43SPL set ID 7474dc53-e5e5-44f2-9f56-b2cbacdc0c32RxCUI 314072UNII 6Z5B6HVF6O

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N425021000102 followed by a unit qualifier and the quantity

Package 25021-0001-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 26, 2025.

Indications (excerpt from the label)

Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Latanoprost ophthalmic solution is a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218257

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218257
Product	Strength	Form · route	Labeler	Product NDC
latanoprost	Latanoprost 50 ug/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-609
latanoprost	Latanoprost 50 ug/mL	Solution/ dropsOphthalmic	GLENMARK PHARMACEUTICALS INC	68462-944